Jennifer D.Bennett

Partner

San Francisco + 1.415.626.3939

Jennifer Bennett advises global technology companies in high-stakes, fast-paced complex litigation involving patents, trademarks, trade secrets, and copyrights. She has a significant track record in jury trials and as the managing lawyer in infringement cases in U.S. District Courts in California, Delaware, and Texas as well as in cases before the United States International Trade Commission (USITC). Jennifer's practice focuses on biopharmaceuticals, medical devices, machine learning, electronics, telecommunications, LED technology, plants, and software applications.

Prior to joining Jones Day in 2022, Jennifer obtained successful outcomes for clients in many cases, including a six-patent case pertaining to optical networking involving wavelength selective switches (WSS) and reconfigurable optical add-drop multiplexer (ROADM) line cards; a multinational consumer electronics company in a patent infringement case involving sophisticated controllers used in video game consoles and equipment for managing motion detection and control systems; patent infringement litigation involving a plant patent on a table grape variety; trade secret litigation involving insurance claim adjudication; patent infringement litigation between competitor medical device companies involving minimally invasive biopsy products; and patent infringement litigation involving information encryption technology.

Jennifer has written and spoken extensively on patent infringement-related topics.

Experience

  • Ag Canada prevails in bifurcated bench trial on identity of so-called "Glory" trees and cherriesJones Day represents Her Majesty the Queen in Right of Canada as represented by the Minister of Agriculture and Agri-Food ("Ag Canada"), in an intellectual property suit against Monson Fruit Company, Inc., Van Well Nursery, Inc., and Gordon and Sally Goodwin.
  • MedImpact wins summary judgment in trade secret case over misuse of its pharmacy benefit management technologyJones Day successfully represented MedImpact Healthcare Systems in this international trade secret litigation against IQVIA arising out of a joint venture relationship.